ArticleMedicine2026
Construction and validation of a risk prediction model for osteoporosis in COPD patients based on explainable machine learning.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To develop a machine learning (ML)-based predictive model for identifying high-risk populations of osteoporosis among patients with chronic obstructive pulmonary disease (COPD), thereby facilitating early detection and personalized management. Using data from patients diagnosed with COPD in the MIMIC-IV database, we divided the dataset into training and validation sets at a 7:3 ratio. LASSO regression and logistic regression were applied to screen 35 variables, and 6 ML algorithms were employed to construct predictive models with internal validation. Model performance was evaluated using multiple metrics, followed by SHAP analysis for interpretability. All 6 ML models achieved high AUC values in both the training and test sets, as measured by the area under the receiver operating characteristic curve, with the XGBoost model demonstrating the highest overall performance. Feature importance analysis revealed that age, sex, and prothrombin time were the top 3 factors influencing osteoporosis risk. This study developed an interpretable ML-based risk prediction model for osteoporosis in COPD patients. The model provides clinicians with a novel tool for individualized osteoporosis risk assessment and early intervention, supporting personalized patient management and improved prognosis. However, this model currently relies on internal validation only and requires external testing in independent cohorts prior to clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.